These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10401913)

  • 41. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.
    Ignjatović Ristić D; Cohen D; Obradović A; Nikić-Đuričić K; Drašković M; Hinić D
    Nord J Psychiatry; 2018 Feb; 72(2):124-129. PubMed ID: 29125018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

  • 46. Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment.
    Kim DD; Barr AM; White RF; Honer WG; Procyshyn RM
    J Psychiatry Neurosci; 2019 Jan; 44(1):71-72. PubMed ID: 30565908
    [No Abstract]   [Full Text] [Related]  

  • 47. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exacerbation of obsessive-compulsive symptoms associated with clozapine.
    Eales MJ; Layeni AO
    Br J Psychiatry; 1994 May; 164(5):687-8. PubMed ID: 7921724
    [No Abstract]   [Full Text] [Related]  

  • 49. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD.
    Biria M; Huang FX; Worbe Y; Fineberg NA; Robbins TW; Fernandez-Egea E
    Eur Neuropsychopharmacol; 2019 Aug; 29(8):905-913. PubMed ID: 31303266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of stringent criteria on eligibility for clozapine among public mental health clients.
    Juarez-Reyes MG; Shumway M; Battle C; Bacchetti P; Hansen MS; Hargreaves WA
    Psychiatr Serv; 1995 Aug; 46(8):801-6. PubMed ID: 7583481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine: more side effects but still the best antipsychotic.
    Kang X; Simpson GM
    J Clin Psychiatry; 2010 Aug; 71(8):982-3. PubMed ID: 20797378
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients.
    Sajatovic M; Ramirez LF; Kenny JT; Meltzer HY
    Compr Psychiatry; 1994; 35(1):29-33. PubMed ID: 8149726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 58. Clozapine as a first treatment for schizophrenia.
    Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
    Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
    J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.